Biosimilars in Oncology Practice: A Multi-Site Health System Examination of the Use and Perception of Oncology Biosimilars.
- Published in:
- Journal of Hematology Oncology Pharmacy, 2024, v. 14, n. 2, p. 83
- By:
- Publication type:
- Article
Works matching IS 21641153 AND DT 2024 AND VI 14 AND IP 2
Results: 4
1
2
Triamterene Cross-Reactivity With Methotrexate Immunoassay: Case Report of Falsely Delayed Methotrexate Clearance During Treatment of High-Grade B-Cell Lymphoma.
- Published in:
- Journal of Hematology Oncology Pharmacy, 2024, v. 14, n. 2, p. 79
- By:
- Publication type:
- Article
3
Real-World Tolerability and Financial Impact of Biosimilar Bevacizumab-awwb Compared With Bevacizumab in Patients With Cancer.
- Published in:
- Journal of Hematology Oncology Pharmacy, 2024, v. 14, n. 2, p. 70
- By:
- Publication type:
- Article
4
The Effect of Dosing Schedule on the Incidence of Immune-Related AEs and Infusion Reactions in Patients Receiving Immunotherapy.
- Published in:
- Journal of Hematology Oncology Pharmacy, 2024, v. 14, n. 2, p. 53
- By:
- Publication type:
- Article